Company · CIK 0000318306 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
ABEONA THERAPEUTICS INC. · ABEO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 SForm 4 → | Sep 1, 5:48 pm EDT | Mark AlvinoDirector | 15,000 | $5.86 | $87,966 | 62,065 | −19.5% | |
| Jul 21, 2026 SForm 4 → | Jul 22, 4:30 pm EDT | Joseph Walter VazzanoChief Financial Officer | 1,478 | $6.53 | $9,651 | 492,079 | −0.30% | |
| Jul 9, 2026 SForm 4 → | Jul 9, 7:24 pm EDT | Joseph Walter VazzanoChief Financial Officer | 24,880 | $6.96 | $173,257 | 493,557 | −4.80% | |
| Jul 9, 2026 SForm 4 → | Jul 9, 7:22 pm EDT | Vishwas SeshadriChief Executive Officer, Director | 67,971 | $6.96 | $473,330 | 1,306,108 | −4.95% | |
| Jul 9, 2026 SForm 4 → | Jul 9, 7:20 pm EDT | Brendan M. O'MalleySVP, Chief Legal Officer | 12,050 | $6.96 | $83,913 | 427,953 | −2.74% | |
| Jul 9, 2026 SForm 4 → | Jul 9, 7:17 pm EDT | Madhav VasanthavadaChief Commercial Officer | 12,606 | $6.96 | $87,784 | 290,623 | −4.16% | |
| Jun 30, 2026 SForm 4 → | Jul 2, 4:30 pm EDT | Leila AllandDirector | 11,000 | $5.92 | $65,087 | 162,614 | −6.34% | |
| Jun 16, 2026 JForm 4 → | Jun 17, 4:30 pm EDT | Madhav VasanthavadaChief Commercial Officer | 222 | $5.67 | $1,259 | 303,229 | — | |
| Jun 15, 2026 SForm 4 → | Jun 15, 7:48 pm EDT | Christine Berni SilversteinDirector | 18,160 | $5.71 | $103,695 | 119,562 | −13.2% | |
| Jun 8, 2026 SForm 4 → | Jun 9, 8:32 pm EDT | Brendan M. O'MalleySVP, Chief Legal Officer | 11,131 | $5.36 | $59,646 | 440,003 | −2.47% | |
| Jun 8, 2026 SForm 4 → | Jun 9, 8:32 pm EDT | Joseph Walter VazzanoChief Financial Officer | 49,338 | $5.38 | $265,242 | 518,437 | −8.69% | 10b5-1 |
| Jun 8, 2026 SForm 4 → | Jun 9, 8:32 pm EDT | Madhav VasanthavadaChief Commercial Officer | 9,620 | $5.36 | $51,549 | 303,451 | −3.07% | |
| Jun 8, 2026 SForm 4 → | Jun 9, 8:32 pm EDT | Vishwas SeshadriChief Executive Officer, Director | 56,344 | $5.36 | $301,921 | 1,374,079 | −3.94% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.